bosentan 32 MG Tablet for Oral Suspension

RxCUI
1989081
RxNorm name
bosentan 32 MG Tablet for Oral Suspension
Display name
bosentan 32 MG Tablet for Oral Suspension
Full name
bosentan 32 MG Tablet for Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bosentanBOSENTANZydus Lifesciences Limitedb88cc559-93ae-42db-9c38-fb5e9c4802e62026-02-14Exact identifier
rxcui: 1989081
TracleerBOSENTANActelion Pharmaceuticals US, Inc.749e42fb-2fe0-45dd-9268-b43bb3f4081c2025-11-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1989081
bosentanBOSENTANZydus Pharmaceuticals USA Inc.c1e75179-cbea-4535-8709-f6d79c1d40042025-11-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1989081
BosentanBOSENTANLupin Pharmaceuticals, Inc.540b6f6a-79f3-4681-8c2a-268cf7cecbc92025-11-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1989081

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
749e42fb-2fe0-45dd-9268-b43bb3f4081cbosentan 32 MG Tablet for Oral Suspension [PSN] · bosentan 32 MG Tablet for Oral Suspension [SCD]236These highlights do not include all the information needed to use TRACLEER safely and effectively. See full prescribing information for TRACLEER. TRACLEER ® (bosentan) tablets, for oral use TRACLEER ® (bosentan) tablets for oral suspension Initial U.S. Approval: 200120251117
540b6f6a-79f3-4681-8c2a-268cf7cecbc9bosentan 32 MG Tablet for Oral Suspension [PSN] · bosentan 32 MG Tablet for Oral Suspension [SCD]27These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets, for oral suspension Initial U.S. Approval: 200120251103
b88cc559-93ae-42db-9c38-fb5e9c4802e6bosentan 32 MG Tablet for Oral Suspension [PSN] · bosentan 32 MG Tablet for Oral Suspension [SCD]21Bosentan Tablets for Oral Suspension20260214
c1e75179-cbea-4535-8709-f6d79c1d4004bosentan 32 MG Tablet for Oral Suspension [PSN] · bosentan 32 MG Tablet for Oral Suspension [SCD]21These highlights do not include all the information needed to use BOSENTAN TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for BOSENTAN TABLETS FOR ORAL SUSPENSION. BOSENTAN tablets for oral suspension Initial U.S. Approval: 200120251112